FDA Inspection 1214698 — Blood Center (The)

Blood Center (The) — FEI 3006611631

The FDA completed an inspection of Blood Center (The) on Jul 26, 2023 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 26, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New Orleans, LA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.